A review of the efficacy and safety of oral antidiabetic drugs
about
Cardiovascular safety of anti-diabetic drugsA Novel TGR5 Activator WB403 Promotes GLP-1 Secretion and Preserves Pancreatic β-Cells in Type 2 Diabetic MiceAnti-Diabetic Effects of Jiang Tang Xiao Ke Granule via PI3K/Akt Signalling Pathway in Type 2 Diabetes KKAy MiceA Novel Diphenylthiosemicarbazide Is a Potential Insulin Secretagogue for Anti-Diabetic AgenDiabetes and cancer: Associations, mechanisms, and implications for medical practice.A novel glycated hemoglobin A1c-lowering traditional Chinese medicinal formula, identified by translational medicine study.Economic impact of combining metformin with dipeptidyl peptidase-4 inhibitors in diabetic patients with renal impairment in spanish patients.Antioxidant, α-glucosidase inhibitory activity and sub-chronic toxicity of Derris reticulata extract: its antidiabetic potential.Polysaccharides from Enteromorpha prolifera Improve Glucose Metabolism in Diabetic Rats.Improving Effect of the Acute Administration of Dietary Fiber-Enriched Cereals on Blood Glucose Levels and Gut Hormone Secretion.Clinical Outcomes of Continuation of Metformin Titration Instructions with Electronic Prescribing.Determinants of weight change in patients on basal insulin treatment: an analysis of the DIVE registry.Cinnamic Acid and Its Derivatives: Mechanisms for Prevention and Management of Diabetes and Its Complications.Compound 19e, a Novel Glucokinase Activator, Protects against Cytokine-Induced Beta-Cell Apoptosis in INS-1 Cells.The bile acid membrane receptor TGR5: a novel pharmacological target in metabolic, inflammatory and neoplastic disorders.An update on the pharmacotherapy options for pediatric diabetes.Metformin in the treatment of non-alcoholic fatty liver disease: safety, efficacy and mechanism.Dipeptidyl peptidase-4 inhibitors: pharmacokinetics, efficacy, tolerability and safety in renal impairment.Novel DPP-4 inhibitors against diabetes.Pharmacological treatment of diabetes in older people.A review of the benefits of Satureja species on metabolic syndrome and their possible mechanisms of action.Management of patients with type 2 diabetes and mild/moderate renal impairment: profile of linagliptin.Adverse Effects Associated With Newer Diabetes Therapies.The treatment of type 1 diabetes mellitus with agents approved for type 2 diabetes mellitus.QSAR studies in the discovery of novel type-II diabetic therapies.Pharmacogenetics: Implications for Modern Type 2 Diabetes Therapy.Free fatty acid receptor agonists for the treatment of type 2 diabetes: drugs in preclinical to phase II clinical development.Cardiovascular effects of anti-diabetes drugs.Is Transforming Stem Cells to Pancreatic Beta Cells Still the Holy Grail for Type 2 Diabetes?Empagliflozin/metformin fixed-dose combination: a review in patients with type 2 diabetes.Rationale for treatment options for mealtime glucose control in patients with type 2 diabetes.Teneligliptin real-world efficacy assessment of type 2 diabetes mellitus patients in India (TREAT-INDIA study)Free Fatty Acid Receptor 1 (FFAR1) as an Emerging Therapeutic Target for Type 2 Diabetes Mellitus: Recent Progress and Prevailing Challenges.Ayurvedic anti-diabetic formulation Lodhrasavam inhibits alpha-amylase, alpha-glucosidase and suppresses adipogenic activity in vitro.Role of insulin resistance in the pathogenesis and development of type 2 diabetes in WBN/Kob-Lepr(fa) ratsSafety and efficacy of the combination of the glucagon-like peptide-1 receptor agonist liraglutide with an oral antidiabetic drug in Japanese patients with type 2 diabetes: post hoc analysis of a randomized, 52-week, open-label, parallel-group trialMyocardin-related transcription factor A regulates conversion of progenitors to beige adipocytes.Overview of clinically approved oral antidiabetic agents for the treatment of type 2 diabetes mellitus.Antidiabetic Potential of Monoterpenes: A Case of Small Molecules Punching above Their Weight.Efficacy and safety of combination therapy with an α-glucosidase inhibitor and a dipeptidyl peptidase-4 inhibitor in patients with type 2 diabetes mellitus: A systematic review with meta-analysis.
P2860
Q26741082-838922EB-E0C2-4E63-BF7B-91A7C1A1305BQ27301757-D12CA0AA-847F-4903-A21B-043F4FAC7572Q28468437-0C0200AE-6B17-4930-9BD7-09EBBD5B4F57Q28552837-30DCE5ED-1F56-4877-B0C0-05D0DCCBBA35Q33759594-4ADF5323-C9FA-458C-BE86-F509DDBA8E8FQ34061542-D79CAC21-DD86-4A35-AE49-2E0A611AB1A9Q35126858-2D360D89-9E2D-47FF-BAEA-47038773ECF4Q35162579-6A95DE9E-6EBE-4A5B-82AD-E2798440B3F7Q35989033-18217126-14AE-4569-9572-35F7C504A3A4Q36509951-C89B9F70-5428-4F8C-AA49-B3A41C9C4D97Q36942830-4ADFF9FB-5799-40A7-A869-5FE3808DB751Q37612059-F1895A26-4D70-42F3-90F6-C25D68A4EBF7Q37673273-178BD47B-363F-40B5-953C-B74A60F066B2Q37725838-8688E0F8-D708-474B-95FD-B26B8DECE9ACQ38115636-189E897D-7C7F-4BB6-8643-3D7782AB6B1CQ38175521-AC84CAF1-D2DA-491A-BFE2-220CA7AED786Q38192049-3F11A17A-91DA-4F1D-A976-7FAAFE6429C3Q38200670-1EAFDE43-45AE-4662-8FA1-EC02E334055DQ38221278-8A93CCD8-D94F-4827-8E26-782C30C9C37BQ38235153-046EA148-0BDE-4389-978C-6A2AFFCB6848Q38309138-030A7577-30AD-4F21-B4BE-4CDBC017EC7BQ38497122-21FC4AEA-23BB-4D93-A9E2-5C1A7AD60016Q38546214-368B52F7-A0E8-4462-B046-2D8E90CA9E40Q38580783-2F37D027-F9B9-469D-965D-43946BACC57AQ38630598-B32CE6C9-4160-49BB-BFEA-54BAABA1C88DQ38816602-62874B72-DBEE-4535-9198-C729672E4ECFQ38832716-F540B980-26A3-4975-8FF6-BCCD2781F44BQ38857056-2385CE94-BD96-40DC-9816-464E89D90BBFQ38867864-46598896-B06F-4064-BF2F-86CC999AABD3Q39000603-D95031ED-46E5-4A8F-9706-3A84D5FA8F40Q39101008-B57C2C8C-FA1E-45DE-AEF9-1D0D100170A9Q39161794-33FE1DE7-2E97-4C06-82D8-FB0431126D93Q39192856-82734B92-68E0-4214-AC72-3CC7D861BB3DQ41689075-FF6B256F-CF7D-421D-8F70-3B86B074C61DQ41816803-5653C5D8-ADA8-45D1-8A49-4875B7F86C25Q42695296-1E41FE73-ABCC-4E82-8C51-D8047C3EAE37Q43215836-4057E8B9-142C-4EC3-896F-026609424DFAQ46207930-90CA25CD-5E57-4F9D-B91B-B052257BA6C7Q47173290-6E4A7ADE-4B19-475B-8098-11BD96C8C008Q47918382-1CAA672C-0158-4002-91F9-DCAACC75F761
P2860
A review of the efficacy and safety of oral antidiabetic drugs
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
A review of the efficacy and safety of oral antidiabetic drugs
@en
type
label
A review of the efficacy and safety of oral antidiabetic drugs
@en
prefLabel
A review of the efficacy and safety of oral antidiabetic drugs
@en
P2093
P2860
P1476
A review of the efficacy and safety of oral antidiabetic drugs
@en
P2093
Elizabeth Mary Lamos
Stephanie Aleskow Stein
Stephen N Davis
P2860
P304
P356
10.1517/14740338.2013.752813
P407
P577
2012-12-14T00:00:00Z